{"entity":{"type":"insider","cik":"0001638474","url":"/insider/0001638474","json_url":"/insider/0001638474.json","name":"Albers Jeffrey W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":162,"n_filings":64,"first":"2015-11-04","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Albers Jeffrey W.","source":"filing","n_filings":64,"first_seen":"2015-11-04","last_seen":"2026-08-10"}],"transactions":[{"id":9293925,"accession":"0001636282-26-000102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001636282-26-000102","line_url":"/filing/0001636282-26-000102#line-3","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":104.68,"price_display":"104.68","price_state":"stated","total_value":1046800.0,"total_display":"1,046,800.00","shares_owned_after":9360.0,"shares_owned_after_display":"9,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-10","scope":"insider"},{"id":9293924,"accession":"0001636282-26-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001636282-26-000102","line_url":"/filing/0001636282-26-000102#line-2","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":104.38,"price_display":"104.38","price_state":"stated","total_value":835040.0,"total_display":"835,040.00","shares_owned_after":19360.0,"shares_owned_after_display":"19,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-10","scope":"insider"},{"id":9293923,"accession":"0001636282-26-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001636282-26-000102","line_url":"/filing/0001636282-26-000102#line-1","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":104.47,"price_display":"104.47","price_state":"stated","total_value":522350.0,"total_display":"522,350.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-10","scope":"insider"},{"id":4344076,"accession":"0001193125-25-311505","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-311505","line_url":"/filing/0001193125-25-311505#line-3","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2748.0,"shares_display":"2,748","price_per_share":89.323,"price_display":"89.32","price_state":"stated","total_value":245459.604,"total_display":"245,459.60","shares_owned_after":2252.0,"shares_owned_after_display":"2,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-08","scope":"insider"},{"id":4344073,"accession":"0001193125-25-311505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-311505","line_url":"/filing/0001193125-25-311505#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2252.0,"shares_display":"2,252","price_per_share":90.3035,"price_display":"90.30","price_state":"stated","total_value":203363.482,"total_display":"203,363.48","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-08","scope":"insider"},{"id":4031516,"accession":"0001193125-25-238130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-238130","line_url":"/filing/0001193125-25-238130#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":59.1898,"price_display":"59.19","price_state":"stated","total_value":295949.0,"total_display":"295,949.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":5158709,"accession":"0000950170-25-081198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-081198","line_url":"/filing/0000950170-25-081198#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6349.0,"shares_display":"6,349","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":311101.0,"total_display":"311,101.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-03","scope":"insider"},{"id":5193892,"accession":"0001415889-25-014862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-014862","line_url":"/filing/0001415889-25-014862#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4350.0,"shares_display":"4,350","price_per_share":101.02,"price_display":"101.02","price_state":"stated","total_value":439437.0,"total_display":"439,437.00","shares_owned_after":147280.0,"shares_owned_after_display":"147,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":5193888,"accession":"0001415889-25-014862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014862","line_url":"/filing/0001415889-25-014862#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":101.93,"price_display":"101.93","price_state":"stated","total_value":66254.5,"total_display":"66,254.50","shares_owned_after":146630.0,"shares_owned_after_display":"146,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":4589255,"accession":"0001415889-25-008112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-008112","line_url":"/filing/0001415889-25-008112#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":87.62,"price_display":"87.62","price_state":"stated","total_value":499434.0,"total_display":"499,434.00","shares_owned_after":154196.0,"shares_owned_after_display":"154,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":4589251,"accession":"0001415889-25-008112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008112","line_url":"/filing/0001415889-25-008112#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":88.37,"price_display":"88.37","price_state":"stated","total_value":159066.0,"total_display":"159,066.00","shares_owned_after":152396.0,"shares_owned_after_display":"152,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":4860866,"accession":"0001415889-25-008211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008211","line_url":"/filing/0001415889-25-008211#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5766.0,"shares_display":"5,766","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":512020.8,"total_display":"512,020.80","shares_owned_after":146630.0,"shares_owned_after_display":"146,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-17","scope":"insider"},{"id":4951363,"accession":"0001415889-25-001989","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-001989","line_url":"/filing/0001415889-25-001989#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7561.0,"shares_display":"7,561","price_per_share":109.11,"price_display":"109.11","price_state":"stated","total_value":824980.71,"total_display":"824,980.71","shares_owned_after":159996.0,"shares_owned_after_display":"159,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4951360,"accession":"0001415889-25-001989","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-001989","line_url":"/filing/0001415889-25-001989#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":109.92,"price_display":"109.92","price_state":"stated","total_value":813408.0,"total_display":"813,408.00","shares_owned_after":152596.0,"shares_owned_after_display":"152,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4951355,"accession":"0001415889-25-001989","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001989","line_url":"/filing/0001415889-25-001989#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":110.61,"price_display":"110.61","price_state":"stated","total_value":22122.0,"total_display":"22,122.00","shares_owned_after":152396.0,"shares_owned_after_display":"152,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4432386,"accession":"0001415889-25-001507","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001507","line_url":"/filing/0001415889-25-001507#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":102.28,"price_display":"102.28","price_state":"stated","total_value":511400.0,"total_display":"511,400.00","shares_owned_after":157557.0,"shares_owned_after_display":"157,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider"},{"id":2392907,"accession":"0001415889-24-029971","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-029971","line_url":"/filing/0001415889-24-029971#line-5","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5180.0,"shares_display":"5,180","price_per_share":89.01,"price_display":"89.01","price_state":"stated","total_value":461071.8,"total_display":"461,071.80","shares_owned_after":163457.0,"shares_owned_after_display":"163,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2392904,"accession":"0001415889-24-029971","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-029971","line_url":"/filing/0001415889-24-029971#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3920.0,"shares_display":"3,920","price_per_share":88.28,"price_display":"88.28","price_state":"stated","total_value":346057.6,"total_display":"346,057.60","shares_owned_after":168637.0,"shares_owned_after_display":"168,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2392900,"accession":"0001415889-24-029971","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-029971","line_url":"/filing/0001415889-24-029971#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":91.15,"price_display":"91.15","price_state":"stated","total_value":346370.0,"total_display":"346,370.00","shares_owned_after":159657.0,"shares_owned_after_display":"159,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2392896,"accession":"0001415889-24-029971","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029971","line_url":"/filing/0001415889-24-029971#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":91.96,"price_display":"91.96","price_state":"stated","total_value":193116.0,"total_display":"193,116.00","shares_owned_after":157557.0,"shares_owned_after_display":"157,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2392603,"accession":"0001415889-24-026594","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026594","line_url":"/filing/0001415889-24-026594#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":102.0,"price_display":"102.00","price_state":"stated","total_value":510000.0,"total_display":"510,000.00","shares_owned_after":157557.0,"shares_owned_after_display":"157,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"},{"id":2097699,"accession":"0001636282-24-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001636282-24-000089","line_url":"/filing/0001636282-24-000089#line-1","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":36.7631,"price_display":"36.76","price_state":"stated","total_value":246312.77,"total_display":"246,312.77","shares_owned_after":27360.0,"shares_owned_after_display":"27,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider"},{"id":2569989,"accession":"0001636282-24-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001636282-24-000070","line_url":"/filing/0001636282-24-000070#line-1","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Spyre Therapeutics, Inc.","issuer_ticker":"SYRE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":36.43,"price_display":"36.43","price_state":"stated","total_value":10929.0,"total_display":"10,929.00","shares_owned_after":34060.0,"shares_owned_after_display":"34,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-25","filed_date":"2024-10-28","scope":"insider"},{"id":3054908,"accession":"0001415889-24-023204","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-023204","line_url":"/filing/0001415889-24-023204#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11968.0,"shares_display":"11,968","price_per_share":85.86,"price_display":"85.86","price_state":"stated","total_value":1027572.48,"total_display":"1,027,572.48","shares_owned_after":165291.0,"shares_owned_after_display":"165,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider"},{"id":3054905,"accession":"0001415889-24-023204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023204","line_url":"/filing/0001415889-24-023204#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7734.0,"shares_display":"7,734","price_per_share":85.12,"price_display":"85.12","price_state":"stated","total_value":658318.08,"total_display":"658,318.08","shares_owned_after":157557.0,"shares_owned_after_display":"157,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider"},{"id":2545758,"accession":"0000950170-24-100660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-100660","line_url":"/filing/0000950170-24-100660#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":49.1017,"price_display":"49.10","price_state":"stated","total_value":245508.5,"total_display":"245,508.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2043396,"accession":"0001415889-24-009009","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-009009","line_url":"/filing/0001415889-24-009009#line-7","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8440.0,"shares_display":"8,440","price_per_share":87.26,"price_display":"87.26","price_state":"stated","total_value":736474.4,"total_display":"736,474.40","shares_owned_after":183702.0,"shares_owned_after_display":"183,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2043395,"accession":"0001415889-24-009009","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-009009","line_url":"/filing/0001415889-24-009009#line-6","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6285.0,"shares_display":"6,285","price_per_share":88.6,"price_display":"88.60","price_state":"stated","total_value":556851.0,"total_display":"556,851.00","shares_owned_after":177417.0,"shares_owned_after_display":"177,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2043394,"accession":"0001415889-24-009009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-009009","line_url":"/filing/0001415889-24-009009#line-5","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6251.0,"shares_display":"6,251","price_per_share":86.46,"price_display":"86.46","price_state":"stated","total_value":540461.46,"total_display":"540,461.46","shares_owned_after":192142.0,"shares_owned_after_display":"192,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2043393,"accession":"0001415889-24-009009","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-009009","line_url":"/filing/0001415889-24-009009#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2730.0,"shares_display":"2,730","price_per_share":85.22,"price_display":"85.22","price_state":"stated","total_value":232650.6,"total_display":"232,650.60","shares_owned_after":198393.0,"shares_owned_after_display":"198,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2043392,"accession":"0001415889-24-009009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-009009","line_url":"/filing/0001415889-24-009009#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1367.0,"shares_display":"1,367","price_per_share":89.12,"price_display":"89.12","price_state":"stated","total_value":121827.04,"total_display":"121,827.04","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider"},{"id":2155561,"accession":"0001415889-24-009169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009169","line_url":"/filing/0001415889-24-009169#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11033.0,"shares_display":"11,033","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":1000582.77,"total_display":"1,000,582.77","shares_owned_after":165017.0,"shares_owned_after_display":"165,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-26","scope":"insider"},{"id":2849258,"accession":"0000950170-24-018246","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-018246","line_url":"/filing/0000950170-24-018246#line-4","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4385.0,"shares_display":"4,385","price_per_share":39.0483,"price_display":"39.05","price_state":"stated","total_value":171226.7955,"total_display":"171,226.80","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-21","scope":"insider"},{"id":2849255,"accession":"0000950170-24-018246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-018246","line_url":"/filing/0000950170-24-018246#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":615.0,"shares_display":"615","price_per_share":39.0746,"price_display":"39.07","price_state":"stated","total_value":24030.879,"total_display":"24,030.88","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":2390147,"accession":"0001415889-24-001931","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-24-001931","line_url":"/filing/0001415889-24-001931#line-6","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10890.0,"shares_display":"10,890","price_per_share":81.7,"price_display":"81.70","price_state":"stated","total_value":889713.0,"total_display":"889,713.00","shares_owned_after":184074.0,"shares_owned_after_display":"184,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2390143,"accession":"0001415889-24-001931","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-001931","line_url":"/filing/0001415889-24-001931#line-5","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7924.0,"shares_display":"7,924","price_per_share":82.76,"price_display":"82.76","price_state":"stated","total_value":655790.24,"total_display":"655,790.24","shares_owned_after":176150.0,"shares_owned_after_display":"176,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2390139,"accession":"0001415889-24-001931","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-001931","line_url":"/filing/0001415889-24-001931#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6086.0,"shares_display":"6,086","price_per_share":81.16,"price_display":"81.16","price_state":"stated","total_value":493939.76,"total_display":"493,939.76","shares_owned_after":194964.0,"shares_owned_after_display":"194,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2390135,"accession":"0001415889-24-001931","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-001931","line_url":"/filing/0001415889-24-001931#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":83.57,"price_display":"83.57","price_state":"stated","total_value":8357.0,"total_display":"8,357.00","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2340639,"accession":"0000950170-24-006766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-006766","line_url":"/filing/0000950170-24-006766#line-2","is_derivative":false,"issuer_cik":"0001638474","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001638474","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.047,"price_display":"30.05","price_state":"stated","total_value":300470.0,"total_display":"300,470.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-23","scope":"insider"},{"id":8035897,"accession":"0001415889-23-016360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016360","line_url":"/filing/0001415889-23-016360#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":79.07,"price_display":"79.07","price_state":"stated","total_value":395350.0,"total_display":"395,350.00","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-13","scope":"insider"},{"id":8035867,"accession":"0001415889-23-015737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-015737","line_url":"/filing/0001415889-23-015737#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.55,"price_display":"70.55","price_state":"stated","total_value":352750.0,"total_display":"352,750.00","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":8035855,"accession":"0001415889-23-015539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-23-015539","line_url":"/filing/0001415889-23-015539#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7964.0,"shares_display":"7,964","price_per_share":67.25,"price_display":"67.25","price_state":"stated","total_value":535579.0,"total_display":"535,579.00","shares_owned_after":183086.0,"shares_owned_after_display":"183,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-24","filed_date":"2023-11-28","scope":"insider"},{"id":8035853,"accession":"0001415889-23-015539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-015539","line_url":"/filing/0001415889-23-015539#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7036.0,"shares_display":"7,036","price_per_share":67.81,"price_display":"67.81","price_state":"stated","total_value":477111.16,"total_display":"477,111.16","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-24","filed_date":"2023-11-28","scope":"insider"},{"id":7959163,"accession":"0001415889-23-014779","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-23-014779","line_url":"/filing/0001415889-23-014779#line-7","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1485.0,"shares_display":"1,485","price_per_share":60.13,"price_display":"60.13","price_state":"stated","total_value":89293.05,"total_display":"89,293.05","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-03","scope":"insider"},{"id":7959158,"accession":"0001415889-23-014779","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-23-014779","line_url":"/filing/0001415889-23-014779#line-5","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4575.0,"shares_display":"4,575","price_per_share":60.36,"price_display":"60.36","price_state":"stated","total_value":276147.0,"total_display":"276,147.00","shares_owned_after":176109.0,"shares_owned_after_display":"176,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":7959156,"accession":"0001415889-23-014779","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-014779","line_url":"/filing/0001415889-23-014779#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59.0,"shares_display":"59","price_per_share":61.05,"price_display":"61.05","price_state":"stated","total_value":3601.95,"total_display":"3,601.95","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":7959149,"accession":"0001415889-23-014779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-014779","line_url":"/filing/0001415889-23-014779#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3881.0,"shares_display":"3,881","price_per_share":60.02,"price_display":"60.02","price_state":"stated","total_value":232937.62,"total_display":"232,937.62","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":7981436,"accession":"0001415889-23-013648","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-23-013648","line_url":"/filing/0001415889-23-013648#line-6","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6898.0,"shares_display":"6,898","price_per_share":50.17,"price_display":"50.17","price_state":"stated","total_value":346072.66,"total_display":"346,072.66","shares_owned_after":176050.0,"shares_owned_after_display":"176,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-29","scope":"insider"},{"id":7981431,"accession":"0001415889-23-013648","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-013648","line_url":"/filing/0001415889-23-013648#line-4","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12102.0,"shares_display":"12,102","price_per_share":49.93,"price_display":"49.93","price_state":"stated","total_value":604252.86,"total_display":"604,252.86","shares_owned_after":176450.0,"shares_owned_after_display":"176,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":7981427,"accession":"0001415889-23-013648","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-23-013648","line_url":"/filing/0001415889-23-013648#line-3","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001638474","owner_name":"Albers Jeffrey W.","owner_url":"/insider/0001638474","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5600.0,"shares_display":"5,600","price_per_share":48.84,"price_display":"48.84","price_state":"stated","total_value":273504.0,"total_display":"273,504.00","shares_owned_after":188552.0,"shares_owned_after_display":"188,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"}],"next_cursor":"2023-09-27|7981427","ledger_fault":false,"count":{"value":162,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":162,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":162},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Spyre Therapeutics, Inc.","url":"/issuer/0001636282","role":"Director","n_filings":3,"first_seen":"2024-10-28","last_seen":"2026-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Director","n_filings":6,"first_seen":"2024-01-23","last_seen":"2025-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Director, Officer (CEO AND PRESIDENT)","n_filings":55,"first_seen":"2015-11-04","last_seen":"2025-05-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001638474","retrieved_at":"2026-08-21T14:33:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}